Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shmuel Yaccoby

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Leukemia & Lymphoma|December 30, 2009
Osteoblastogenesis and tumor growth in myelomaShmuel Yaccoby
Clinical Lymphoma, Myeloma & Leukemia|October 26, 2017
Two States of Myeloma Stem CellsShmuel Yaccoby
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotypeShmuel Yaccoby
British Journal of Haematology|March 17, 2010
Advances in the understanding of myeloma bone disease and tumour growthShmuel Yaccoby
The Hematology Journal : the Official Journal of the European Haematology Association|September 23, 2003
Consequences of interactions between the bone marrow stroma and myelomaJoshua Epstein, Shmuel Yaccoby
Methods in Molecular Medicine|June 22, 2005
The SCID-hu myeloma modelJoshua Epstein, Shmuel Yaccoby
Blood|April 26, 2008
Role of decorin in the antimyeloma effects of osteoblastsXin Li, Angela Pennisi, Shmuel Yaccoby
Blood|March 18, 2008
Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growthYa-Wei Qiang, John D Shaughnessy, Shmuel Yaccoby
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 31, 2012
Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growthXin Li, Wen Ling, Sharmin Khan, et al.
Cancer Letters|May 19, 2009
Fenretinide inhibits myeloma cell growth, osteoclastogenesis and osteoclast viabilityXin Li, Wen Ling, Angela Pennisi, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|December 30, 2009
Osteoblastogenesis and tumor growth in myelomaShmuel Yaccoby
Clinical Lymphoma, Myeloma & Leukemia|October 26, 2017
Two States of Myeloma Stem CellsShmuel Yaccoby
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotypeShmuel Yaccoby
British Journal of Haematology|March 17, 2010
Advances in the understanding of myeloma bone disease and tumour growthShmuel Yaccoby
The Hematology Journal : the Official Journal of the European Haematology Association|September 23, 2003
Consequences of interactions between the bone marrow stroma and myelomaJoshua Epstein, Shmuel Yaccoby
Methods in Molecular Medicine|June 22, 2005
The SCID-hu myeloma modelJoshua Epstein, Shmuel Yaccoby
Blood|April 26, 2008
Role of decorin in the antimyeloma effects of osteoblastsXin Li, Angela Pennisi, Shmuel Yaccoby
Blood|March 18, 2008
Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growthYa-Wei Qiang, John D Shaughnessy, Shmuel Yaccoby
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 31, 2012
Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growthXin Li, Wen Ling, Sharmin Khan, et al.
Cancer Letters|May 19, 2009
Fenretinide inhibits myeloma cell growth, osteoclastogenesis and osteoclast viabilityXin Li, Wen Ling, Angela Pennisi, et al.
Pageof 7